Strategic Partnership to Bring Hope to Patients With Fibrotic and Inflammatory Diseases
In January 2020, the partnership between Enleofen Bio and the global pharmaceutical company, Boehringer Ingelheim was announced, to enhance the interleukin-11 programme and advance it to clinical...